Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
490.30
+2.93 (+0.60%)
Streaming Delayed Price
Updated: 10:25 AM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
May 15, 2024
Pfizer is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform.
Via
Benzinga
Exposures
COVID-19
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
May 14, 2024
On Tuesday, Catalyst Pharmaceuticals stock hit a key technical milestone, with its Relative Strength Rating climbing to 83 from 79.
Via
Investor's Business Daily
3 Cheap Biotech Stocks to Buy Now: May 2024
May 14, 2024
Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market.
Via
InvestorPlace
Exposures
Product Safety
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
May 14, 2024
Via
Benzinga
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
May 12, 2024
The biotech's shares dropped following its latest quarterly update, but that shouldn't matter to long-term investors.
Via
The Motley Fool
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
May 08, 2024
Via
Benzinga
Smart Money Is Betting Big In VRTX Options
May 06, 2024
Via
Benzinga
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
May 12, 2024
These companies are raking in profits at astonishing clips.
Via
The Motley Fool
Stock Market Moves Toward Highs; Arista, Toast, Palantir Key Earnings Movers: Weekly Review
May 10, 2024
Big earnings winners and losers continued.
Via
Investor's Business Daily
Will the Biotech Sector Shift From Lagger to Leader?
May 10, 2024
The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.
Via
MarketBeat
Topics
ETFs
Investors seeking growth at a reasonable cost should explore NASDAQ:VRTX.
May 08, 2024
While growth is established for NASDAQ:VRTX, the stock's valuation remains reasonable.
Via
Chartmill
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
May 08, 2024
New drugs in development and a lack of significant patent cliffs ahead make this a great pharma stock to buy now and hold over the long run.
Via
The Motley Fool
Topics
Intellectual Property
Exposures
Intellectual Property
Markets In A Minute - "A Lack Of Further Progress"
May 07, 2024
May's FOMC meeting left the Fed Funds Rate unchanged. JOLTS showed fewer job openings with increased layoffs. April's job report disappointed, adding only 175k jobs and seeing higher unemployment....
Via
Talk Markets
Topics
Economy
Workforce
Exposures
Interest Rates
Layoff
10 Health Care Stocks With Whale Alerts In Today's Session
May 07, 2024
Via
Benzinga
US Stocks Eye Fourth Positive Session Despite Hawkish Fed Remarks; Disney, Palantir Tumble; Treasury Yields Fall: What's Driving Markets Tuesday?
May 07, 2024
Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data and minimal updates on earnings from major large-cap companies.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
VRTX Stock Earnings: Vertex Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
VRTX stock results show that Vertex Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
May 06, 2024
VRTX earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Vertex Beats First-Quarter Expectations, But Shares Stay Flat On Reiterated Outlook
May 06, 2024
Vertex Pharmaceuticals beat first-quarter sales and earnings forecasts.
Via
Investor's Business Daily
Vertex Reports First Quarter 2024 Financial Results
May 06, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
3 Biotech Stocks to Double Your Money in the Next 24 Months
May 06, 2024
The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates.
Via
InvestorPlace
3 No-Brainer Stocks to Buy in May
May 05, 2024
These great stocks are great picks for investors as spring winds down.
Via
The Motley Fool
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
May 04, 2024
Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.
Via
InvestorPlace
Exposures
Product Safety
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
May 03, 2024
Earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation report.
Via
Investor's Business Daily
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
May 03, 2024
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.
Via
InvestorPlace
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
May 03, 2024
Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns.
Via
InvestorPlace
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
May 03, 2024
Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.
Via
InvestorPlace
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
May 02, 2024
Via
Benzinga
2 Top Growth Stocks to Buy Right Now and Hold Forever
April 28, 2024
These healthcare stocks can provide enviable long-term portfolio growth.
Via
The Motley Fool
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.
April 27, 2024
These three should have a lot of room to run.
Via
The Motley Fool
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
April 26, 2024
Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising non-opioid painkillers.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.